4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001140361-18-009664
Options or other derivatives
- Chief Business Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schuchart Aaron · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-02-20 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X03/doc1.xml…